Ardsley, NY, United States of America

Ciba-Geiby Corporation


USPTO Granted Patents = 7

Forward Citations = 97

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Dieter Reinehr (1 out of 113 patents)

silverMedal Dirk Vetter (1 out of 7 patents)

bronzeMedal Friedrich Karrer (1 out of 87 patents)

4.  Urs Burckhardt (1 out of 11 patents)

5.  Jurgen Finter (1 out of 43 patents)

6.  Brian G Clubley (1 out of 19 patents)

7.  Ernst Beriger (1 out of 32 patents)

8.  Rosemarie Topfl (1 out of 39 patents)

9.  Heinz Abel (1 out of 52 patents)

10.  Wolfgang Wernet (1 out of 20 patents)

11.  Friedrich Lohse (1 out of 41 patents)

12.  Hartmut Bleier (1 out of 2 patents)

13.  Thomas Vogel (1 out of 2 patents)

14.  Bruno Rotzinger (1 out of 1 patent)

15.  Manfred Kuhne (1 out of 11 patents)


7 patents:

Company Overview
Ciba-Geiby Corporation is a leading pharmaceutical company specializing in the research, development, and manufacturing of innovative medicines. With a focus on improving patient outcomes and quality of life, Ciba-Geiby is committed to advancing healthcare through cutting-edge technology and groundbreaking discoveries in the field of medicine. Our dedicated team of scientists, researchers, and healthcare professionals work tirelessly to bring effective therapies to patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#6 in Ardsley, NY

#2,359 in New York

#39,907 in US

Ardsley, NY (US)
Ardsley, NY, United States of America
Forward Citations = 97

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ciba-Geiby Corporation. Retrieved from https://idiyas.com/company/ciba-geiby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…